These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 6249197

  • 1. In vitro activities of miconazole, miconazole nitrate, and ketoconazole alone and combined with rifampin against Candida spp. and Torulopsis glabrata recovered from cancer patients.
    Moody MR, Young VM, Morris MJ, Schimpff SC.
    Antimicrob Agents Chemother; 1980 May; 17(5):871-5. PubMed ID: 6249197
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. In-vitro antifungal activity of sertaconazole, bifonazole, ketoconazole, and miconazole against yeasts of the Candida genus.
    Carrilo-Muñoz AJ, Tur C, Torres J.
    J Antimicrob Chemother; 1996 Apr; 37(4):815-9. PubMed ID: 8722548
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. In vitro antifungal activity of saperconazole (R 66905) against Candida and Torulopsis.
    Mallié M, Montès B, Lebecq JC, Bastide JM.
    Mycoses; 1989 Dec; 32(12):631-7. PubMed ID: 2695841
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Comparison of miconazole- and ketoconazole-induced release of K+ from Candida species.
    Beggs WH.
    J Antimicrob Chemother; 1983 Apr; 11(4):381-3. PubMed ID: 6304001
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Comparison of the in vitro antifungal activities of miconazole and a new imidazole, R41,400.
    Dixon D, Shadomy S, Shadomy HJ, Espinel-Ingroff A, Kerkering TM.
    J Infect Dis; 1978 Aug; 138(2):245-8. PubMed ID: 681800
    [Abstract] [Full Text] [Related]

  • 12. [In vitro antifungal activity of itraconazole, a new triazole antifungal agent, against clinical isolates from patients with systemic mycoses].
    Uchida K, Matsuzaka A, Aoki K, Yamaguchi H.
    Jpn J Antibiot; 1991 May; 44(5):562-70. PubMed ID: 1652654
    [Abstract] [Full Text] [Related]

  • 13. Susceptibility of zygomycetes to amphotericin B, miconazole, and ketoconazole.
    Eng RH, Person A, Mangura C, Chmel H, Corrado M.
    Antimicrob Agents Chemother; 1981 Nov; 20(5):688-90. PubMed ID: 6275783
    [Abstract] [Full Text] [Related]

  • 14. In vitro activity of sertaconazole, fluconazole, ketoconazole, fenticonazole, clotrimazole and itraconazole against pathogenic vaginal yeast isolates.
    Palacín C, Tarragó C, Agut J, Guglietta A.
    Methods Find Exp Clin Pharmacol; 2001 Mar; 23(2):61-4. PubMed ID: 11484411
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Comparative evaluation of PASCO and national committee for clinical laboratory standards M27-A broth microdilution methods for antifungal drug susceptibility testing of yeasts.
    Arthington-Skaggs BA, Motley M, Warnock DW, Morrison CJ.
    J Clin Microbiol; 2000 Jun; 38(6):2254-60. PubMed ID: 10834985
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.